Clinical trial
Primary Ciliary Dyskinesia New Gene Discovery to Improve Diagnostics and Clinical Care
NCT03801395 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Primary Ciliary Dyskinesia New Gene Discovery to Improve Diagnostics and Clinical Care
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 7, 2019
- Completion date
- November 20, 2024
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary ciliary dyskinesia